bioRxiv · 10.1101/242545
Evaluation of gene-based family-based methods to detect novel genes associated with familial late onset Alzheimer disease
Abstract
Gene-based tests to study the combined effect of rare variants towards a particular phenotype have been widely developed for case-control studies, but their evolution and adaptation for family-based studies, especially for complex incomplete families, has been slower. In this study, we have performed a practical examination of all the latest gene-based methods available for family-based study designs using both simulated and real datasets. We have examined the performance of several collapsing, variance-component and transmission disequilibrium tests across eight different software and twenty-two models utilizing a cohort of 285 families (N=1,235) with late-onset Alzheimer disease (LOAD). After a thorough examination of each of these tests, we propose a methodological approach to identify, with high confidence, genes associated with the studied phenotype with high confidence and we provide recommendations to select the best software and model for family-based gene-based analyses. Additionally, in our dataset, we identified PTK2B, a GWAS candidate gene for sporadic AD, along with six novel genes (CHRD, CLCN2, HDLBP, CPAMD8, NLRP9, MAS1L) as candidates genes for familial LOAD.
Source connections
Explore related subjects
Keep this discovery
Cruchaga, C., Feranndez, M. V., Budde, J., Del-Aguila, J., Ibanez, L., Deming, Y., Harari, O., Norton, J., Morris, J. C., Goate, A.. 2018-01-08. Evaluation of gene-based family-based methods to detect novel genes associated with familial late onset Alzheimer disease. https://doi.org/10.1101/242545
Cite the original work for its findings. Save a collection to share your selection of sources.